Literature DB >> 2107138

Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms.

D C Miller1, M Koslow, G N Budzilovich, D E Burstein.   

Abstract

Synaptophysin, a 38-kilodalton glycoprotein found in synaptic vesicle membranes, has been shown to be a sensitive marker of neuroendocrine differentiation in non-central nervous system (CNS) tumors. We analyzed the patterns of synaptophysin immunoreactivity in CNS neoplasms in comparison with various normal CNS sites in biopsies. Normal gray matter structures all showed a diffuse punctate granular pattern of neuropil staining without staining of neuronal cell bodies. In contrast, neoplastic ganglion cells in 18 of 18 gangliogliomas/gangliocytomas showed intense immunoreactivity outlining the borders of the cell bodies. Focal staining was also seen in five of 16 primitive neuroectodermal tumors and in one of three central neurocytomas, but these tumors had a finely granular neuropil pattern of immunoreactivity more like that of normal gray matter than like that of the gangliogliomas. All 35 examples of pure gliomas of various types showed no immunoreactivity. Our data highlight synaptophysin as a sensitive and specific marker of both neuronal lineage and neoplastic character in gangliogliomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107138     DOI: 10.1016/0046-8177(90)90226-u

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Pleomorphic primitive neuroectodermal tumor with glial and neuronal differentiation: clinical, pathological, cultural, and chromosomal analysis of a case.

Authors:  Yuji Uematsu; Rie Takehara; Mina Shimizu; Yoshiyuki Tanaka; Toru Itakura; Norihiko Komai
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

Review 2.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

3.  Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.

Authors:  K Washiyama; Y Muragaki; L B Rorke; V M Lee; S C Feinstein; M J Radeke; D Blumberg; D R Kaplan; J Q Trojanowski
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Surgical pathology of intramedullary spinal cord neoplasms.

Authors:  D C Miller
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

5.  So-called malignant and extra-ventricular neurocytomas: reality or wrong diagnosis? A critical review about two overdiagnosed cases.

Authors:  A V Vallat-Decouvelaere; P Gauchez; P Varlet; M B Delisle; M Popovic; H Boissonnet; M Gigaud; J Mikol; J Hassoun
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

6.  Spinal cord gangliogliomas: a review of 56 patients.

Authors:  George I Jallo; Diana Freed; Fred J Epstein
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

7.  Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

Authors:  Seth C Lummus; Dara L Aisner; Sharon B Sams; Nicholas K Foreman; Kevin O Lillehei; B K Kleinschmidt-DeMasters
Journal:  Am J Clin Pathol       Date:  2014-08       Impact factor: 2.493

Review 8.  Gangliogliomas: a clinicopathological study of 25 cases and review of the literature.

Authors:  H G Krouwer; R L Davis; M W McDermott; T Hoshino; M D Prados
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

Review 9.  Giant central neurocytoma with tetraventricular and extra-axial extension. Case report.

Authors:  P H Roche; S Malca; D Gambarelli; W Pellet
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

10.  Supraspinal fiber outgrowth and apparent synaptic remodelling across transected-reconstructed feline spinal cord.

Authors:  J C de la Torre; H S Goldsmith
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.